Raymond James Financial Inc. bought a new position in shares of Addus HomeCare Co. (NASDAQ:ADUS - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 52,948 shares of the company's stock, valued at approximately $6,637,000. Raymond James Financial Inc. owned 0.29% of Addus HomeCare at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Smartleaf Asset Management LLC boosted its position in shares of Addus HomeCare by 324.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock worth $35,000 after acquiring an additional 214 shares during the last quarter. Parkside Financial Bank & Trust boosted its position in Addus HomeCare by 38.6% during the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock worth $67,000 after purchasing an additional 148 shares during the period. Meeder Asset Management Inc. purchased a new stake in shares of Addus HomeCare during the 4th quarter valued at about $77,000. Harvest Fund Management Co. Ltd purchased a new position in Addus HomeCare in the 4th quarter worth approximately $86,000. Finally, KBC Group NV grew its stake in Addus HomeCare by 49.1% in the fourth quarter. KBC Group NV now owns 814 shares of the company's stock worth $102,000 after purchasing an additional 268 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms have commented on ADUS. Oppenheimer lifted their price objective on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. JMP Securities reissued a "market outperform" rating and issued a $150.00 target price on shares of Addus HomeCare in a report on Tuesday, April 22nd. Stephens reaffirmed an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie reissued an "outperform" rating and issued a $129.00 price target on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, StockNews.com lowered Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare currently has an average rating of "Buy" and an average target price of $139.00.
Check Out Our Latest Research Report on ADUS
Addus HomeCare Stock Performance
Shares of NASDAQ:ADUS traded down $0.31 during midday trading on Tuesday, reaching $100.72. The company had a trading volume of 8,199 shares, compared to its average volume of 162,011. The company has a fifty day simple moving average of $97.69 and a two-hundred day simple moving average of $115.78. The firm has a market cap of $1.83 billion, a price-to-earnings ratio of 22.97, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare Co. has a 1-year low of $88.96 and a 1-year high of $136.72.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The company had revenue of $297.14 million for the quarter, compared to the consensus estimate of $291.04 million. Analysts expect that Addus HomeCare Co. will post 4.59 EPS for the current year.
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
